GlobalData on MSN1d
Lipocine’s Phase III trial of LPCN 1154 to begin for postpartum depressionThe trial will compare the therapy against a placebo in women aged 15 years and above who are diagnosed with severe PPD.
Lomond Therapeutics Holdings, Inc. ("Lomond Therapeutics"), a clinical-stage biotechnology company dedicated to discovering ...
Aura Biosciences (AURA) has reported its Q4 and full-year 2024 financial results, prompting an ongoing decline in shares ...
Positive azenosertib clinical data demonstrated clinically meaningful results in patients with Cyclin E1+ platinum-resistant ovarian cancer ...
PRESS RELEASE Urteste plans to start clinical trials for its pancreatic cancer test in Europe in Q3 2025 Gdansk, Poland - 27 March 2025 - Urteste S.A. (Warsaw Stock ...
WESTLAKE VILLAGE, Calif., March 28, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, reported fourth quarter and full year 2024 financial ...
Medscape Medical News speaks with Jiha Lee to discuss how to provide holistic, patient-centered care for older adults living ...
MedPage Today on MSN4d
Deciding Whether Multiple Sclerosis Treatment Should Be DiscontinuedObservational studies and two randomized controlled trials consistently suggest that, in general, disease recurrence after ...
LifeTech Scientific Corporation (the "Company" or "LifeTech", Stock code: 1302.HK), a company specializing in minimally ...
Skin cancer advanced clinical practitioners ensure continuity of care for patients with malignant melanoma and other advanced ...
Pulmonary hypertension is a common consequence of interstitial lung disease (PH-ILD), with the highest rate seen among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback